Dong-A ST Demonstrates Preclinical Potential of Topical Icotrokinra Formulation for Psoriasis

Posted on by sHq_LoGiNz

SEOUL, South Korea–(BUSINESS WIRE)– #AAPSPharmSci360–Dong-A ST, a Korean pharma company, presented preclinical data at AAPS PharmSci 360 2026 on developing Icotrokinra as a topical psoriasis treatment.

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance (opens in a new tab)
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.